Segall Bryant & Hamill LLC cut its position in Hawkins, Inc. (NASDAQ:HWKN – Free Report) by 4.9% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 88,021 shares of the specialty chemicals company’s stock after selling 4,556 shares during the period. Segall Bryant & Hamill LLC’s holdings in Hawkins were worth $13,520,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors have also recently bought and sold shares of the company. Vanguard Group Inc. lifted its holdings in Hawkins by 1.4% during the 4th quarter. Vanguard Group Inc. now owns 1,525,789 shares of the specialty chemicals company’s stock worth $216,754,000 after buying an additional 20,958 shares during the last quarter. State Street Corp lifted its position in shares of Hawkins by 11.6% during the 4th quarter. State Street Corp now owns 1,067,451 shares of the specialty chemicals company’s stock worth $151,642,000 after buying an additional 111,318 shares during the last quarter. Wasatch Advisors LP boosted its holdings in shares of Hawkins by 31.4% in the 4th quarter. Wasatch Advisors LP now owns 552,419 shares of the specialty chemicals company’s stock valued at $78,477,000 after buying an additional 131,850 shares in the last quarter. Geode Capital Management LLC lifted its position in Hawkins by 2.8% in the fourth quarter. Geode Capital Management LLC now owns 513,535 shares of the specialty chemicals company’s stock valued at $72,965,000 after acquiring an additional 13,828 shares during the last quarter. Finally, Capital World Investors boosted its stake in Hawkins by 34.4% in the fourth quarter. Capital World Investors now owns 477,985 shares of the specialty chemicals company’s stock valued at $67,903,000 after acquiring an additional 122,366 shares in the last quarter. Hedge funds and other institutional investors own 69.71% of the company’s stock.
Hawkins Trading Down 0.9%
Shares of HWKN stock opened at $128.03 on Friday. The company has a market capitalization of $2.67 billion, a P/E ratio of 33.17, a price-to-earnings-growth ratio of 2.31 and a beta of 0.78. The company has a current ratio of 2.27, a quick ratio of 1.46 and a debt-to-equity ratio of 0.45. The business’s 50 day moving average is $148.53 and its two-hundred day moving average is $149.93. Hawkins, Inc. has a twelve month low of $117.98 and a twelve month high of $186.15.
Hawkins Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 28th. Investors of record on Friday, August 14th will be given a $0.19 dividend. The ex-dividend date is Friday, August 14th. This represents a $0.76 dividend on an annualized basis and a yield of 0.6%. Hawkins’s dividend payout ratio (DPR) is presently 19.69%.
Wall Street Analyst Weigh In
HWKN has been the subject of several research reports. Barclays set a $142.00 target price on Hawkins and gave the company an “equal weight” rating in a report on Friday. Weiss Ratings cut shares of Hawkins from a “buy (b-)” rating to a “hold (c+)” rating in a report on Tuesday, July 14th. One research analyst has rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, Hawkins has a consensus rating of “Hold” and an average target price of $171.00.
Get Our Latest Research Report on HWKN
Hawkins Company Profile
Hawkins, Inc (NASDAQ: HWKN) is a specialty chemical company that produces and distributes water-treatment and industrial chemicals across North America. Founded in 1938 and headquartered in Roseville, Minnesota, the company has built a network of manufacturing facilities and distribution centers that serve municipal, industrial and commercial customers. As a publicly traded entity, Hawkins leverages its long-standing presence in the chemical distribution industry to provide tailored solutions for complex water-treatment challenges and specialty chemical needs.
Hawkins’ product portfolio encompasses a wide range of chemicals, including sodium hypochlorite, sodium hydroxide, hydrogen peroxide, chlorine, acids and specialty blends.
Read More
- Five stocks we like better than Hawkins
- Popular’s Earnings Beat Shows Why This Bank Stock Keeps Climbing
- ABB’s Rotork Deal Could Put These Flow Control Stocks Back in Focus
- GE HealthCare Stock Climbs on Vital Diagnostics Demand
- Lost in Space: Why Aerospace Valuations Are Plummeting Right Now
Want to see what other hedge funds are holding HWKN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hawkins, Inc. (NASDAQ:HWKN – Free Report).
Receive News & Ratings for Hawkins Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hawkins and related companies with MarketBeat.com's FREE daily email newsletter.
